Natco Pharma Announces ₹2,500 Crore South Africa Investment; Share Price Gain on Expansion Plans

Natco Pharma share price (NSE: NATCOPHARM) gained during trading on July 9, 2026, after the pharmaceutical company announced an investment of nearly ₹2,500 crore in South Africa. The investment includes increasing its stake in Adcock Ingram Holdings Proprietary Limited and infusing additional capital into its South African subsidiary to support future expansion.

Natco Pharma Unveils ₹2,500 Crore Investment Plan

Natco Pharma said it plans to invest around ₹2,500 crore in South Africa to strengthen its presence in the region and enter new international markets.

As part of the plan, the company will:

• Invest ₹1,400 crore in its wholly owned subsidiary, Natco Pharma South Africa Proprietary Limited.
• Increase its stake in Adcock Ingram Holdings Proprietary Limited from 35.75% to 49%. 

The acquisition of the additional stake is valued at approximately ₹1,069 crore and is expected to be completed before the end of July 2026.

Expansion Across African Markets

Natco Pharma said the investment is aimed at expanding its geographical footprint across South Africa and the wider African continent.

Founded in 1890, Adcock Ingram is a leading South African pharmaceutical company with operations across:

• Prescription medicines
• Consumer healthcare products
• Over-the-counter (OTC) medicines
• Hospital products 

The company offers a broad portfolio that includes generic medicines, branded formulations and healthcare products.

Natco Pharma Share Price Movement

Following the announcement, Natco Pharma share price rose during the trading session.

The stock opened at ₹966.35 on the NSE and touched an intraday high of ₹989.50. Earlier in the session, the shares were trading nearly 2% higher, outperforming the broader market.

So far in 2026, Natco Pharma shares have gained around 11%, while the Nifty 50 has declined by approximately 8% during the same period.

Read More: Dividend Stocks This Week (July 6 – 10): Mphasis, Titan, Nestlé India, Axis Bank and 41 Others to Trade Ex-Dividend!

Conclusion

Natco Pharma's ₹2,500 crore investment plan highlights its strategy to strengthen its presence in South Africa and expand into other African markets. 

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.